ijms-logo

Journal Browser

Journal Browser

Advances in Protein Structure-Function and Drug Discovery

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Macromolecules".

Deadline for manuscript submissions: 20 March 2026 | Viewed by 1675

Special Issue Editors


E-Mail Website
Guest Editor
Institute for Biotechnology and Biomedicine, Universitat Autònoma de Barcelona, Campus Universitari, Bellaterra, Cerdanyola del Vallès, 08193 Barcelona, Spain
Interests: proteolytic enzymes and inhibitors; natural/synthetic inhibitors and ligands; structure-function; proteomics; molecular imaging; drug-discovery and screening
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
The Molecular Biology Institute of Barcelona (IBMB-CSIC), 08193 Barcelona, Spain
Interests: protein; proteolytic enzymes; peptidases and their zymogens

Special Issue Information

Dear Colleagues,

Proteins are among the most active, essential and sophisticated molecules in the biological world, and key players in the biotechnological and biomedical fields. The roles and functionality of a protein are generally strongly dependent of its defined amino acid sequence, modifications, tridimensional structure (tertiary, quaternary) and environment, that is from its precise structure. Because of this, the structure-function relationships of a protein are considered the core of its behavior and properties, both at the fundamental and biotech/biomed applicative levels. Such properties are also essential when the design and derivation of drugs (inhibitors, activators, regulators ...) is considered for a given protein, or a family of them, and have to be taken into account in the drug discovery procedures and approaches.

In the here launched Special Issue all these components will be considered to promote and select research works addressed to such issue, and particularly on the following items:

  • Novelties and refinements on protein structure, protein function and relationships, particularly when related with the discovery and characterization of protein drug-targets. Also, with the derivation or refinement of drugs or drug families from them.
  • Structure-based fundamentals of the functionality and specific role of proteins, and on the discovery of drugs that could act on its inhibition, activation or regulation.
  • Development and improvement of approaches to facilitate the discovery and derivation of protein-directed drugs or lead compounds, either from natural or synthetic resources.

Prof. Dr. Francesc Xavier Avilés
Prof. Dr. F. Xavier Gomis-Rüth
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • protein structure
  • protein function
  • protein drug target
  • inhibition
  • protein structure-function
  • protein drug discovery
  • protein inhibition
  • protein activation
  • protein regulation
  • protein structure-function and evolution
  • protein structure-function engineering and design
  • protein structure-function and drug discovery

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (3 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Review, Other

17 pages, 4373 KB  
Article
Discovery and Characterization of Novel Non-Hydroxamate HDAC11 Inhibitors
by Aleksandra Kopranovic and Franz-Josef Meyer-Almes
Int. J. Mol. Sci. 2025, 26(13), 5950; https://doi.org/10.3390/ijms26135950 - 20 Jun 2025
Cited by 1 | Viewed by 1010
Abstract
Histone deacetylase 11 (HDAC11), the sole member of class IV HDACs, has gained prominence due to its unique enzymatic profile and pathological relevance in cancer, neurodegenerative, inflammatory diseases, and metabolic disorders. However, only a limited number of selective HDAC11 inhibitors have been identified, [...] Read more.
Histone deacetylase 11 (HDAC11), the sole member of class IV HDACs, has gained prominence due to its unique enzymatic profile and pathological relevance in cancer, neurodegenerative, inflammatory diseases, and metabolic disorders. However, only a limited number of selective HDAC11 inhibitors have been identified, and many of these contain a potentially mutagenic hydroxamic acid as a zinc-chelating motif. Consequently, there is an imperative to identify potent and selective non-hydroxamate HDAC11 inhibitors with improved physicochemical properties. In this study, we conducted an extensive experimental high-throughput screening of 10,281 structurally diverse compounds to identify novel HDAC11 inhibitors. Two promising candidates, caffeic acid phenethyl ester (CAPE) and compound 9SPC045H03, both lacking a hydroxamic acid warhead, were discovered, showing micromolar inhibitory potency (IC50 = 1.5 and 2.3 µM, respectively), fast and reversible binding, and remarkable isozyme selectivity. Molecular docking revealed distinct zinc-chelating mechanisms involving either carbonyl oxygen (CAPE) or pyridine nitrogen (9SPC045H03), in contrast to canonical hydroxamates. Both compounds are drug-like and exhibit favorable physicochemical and pharmacokinetic profiles, particularly beneficial water solubility and good adsorption, making them valuable starting points for further optimization. These findings open new avenues for the development of selective, non-hydroxamate HDAC11 inhibitors with potential therapeutic applications. Full article
(This article belongs to the Special Issue Advances in Protein Structure-Function and Drug Discovery)
Show Figures

Graphical abstract

Review

Jump to: Research, Other

15 pages, 1208 KB  
Review
Is dUTPase Enzymatic Activity Truly Essential for Viability?
by Anatoly Glukhov, Ulyana Dzhus, Ilya Kolyadenko, Georgii Selikhanov and Azat Gabdulkhakov
Int. J. Mol. Sci. 2025, 26(19), 9260; https://doi.org/10.3390/ijms26199260 - 23 Sep 2025
Viewed by 329
Abstract
The study of protein enzymatic activities has always been a significant area of scientific and industrial research. The key steps typically undertaken in the characterization of a certain enzyme family include establishing the mechanism of catalysis, measuring kinetic parameters, determining structural organization and [...] Read more.
The study of protein enzymatic activities has always been a significant area of scientific and industrial research. The key steps typically undertaken in the characterization of a certain enzyme family include establishing the mechanism of catalysis, measuring kinetic parameters, determining structural organization and the architecture of the catalytic center, and subsequent classification. In this review, we tried to touch upon only a few points from the classical description of enzymes of the dUTPase family and added some additional functional properties of a number of representatives of this family. The existence of such extra functions raises questions about the reasons for this function duality. Based on the information known in the literature and our previous research, in this review, we conclude that the enzymatic activity of dUTPases supplements other functions independent of the hydrolysis reaction occurring in the catalytic center. In this context, it seems that dUTP acts not just as a substrate but as a signaling molecule, whose binding induces the realization of a special, non-enzymatic role of dUTPases. Full article
(This article belongs to the Special Issue Advances in Protein Structure-Function and Drug Discovery)
Show Figures

Figure 1

Other

Jump to: Research, Review

11 pages, 741 KB  
Brief Report
Moonlighting Proteins: Some Hypotheses on the Structural Origin of Their Multifunctionality
by Juan Cedano, Mario Huerta, Angel Mozo-Villarias and Enrique Querol
Int. J. Mol. Sci. 2025, 26(21), 10375; https://doi.org/10.3390/ijms262110375 (registering DOI) - 24 Oct 2025
Abstract
Moonlighting proteins—single polypeptides performing multiple, often unrelated functions—are increasingly recognized as key players in human disease and microbial pathogenesis, making their identification crucial for understanding disease mechanisms and developing targeted therapies. This study addresses the unresolved question of how such multifunctionality evolves, focusing [...] Read more.
Moonlighting proteins—single polypeptides performing multiple, often unrelated functions—are increasingly recognized as key players in human disease and microbial pathogenesis, making their identification crucial for understanding disease mechanisms and developing targeted therapies. This study addresses the unresolved question of how such multifunctionality evolves, focusing on two potential structural mechanisms: Non-Orthologous Gene Displacement/Non-Homologous Isofunctional Enzymes (NOGD/NHIE), where evolutionarily unrelated proteins perform the same function, and Fold-Switching Proteins (FSP), which adopt alternative secondary structures to switch functions without sequence changes. We analyzed the overlap between known human moonlighting proteins (from MultitaskProtDB-II) and curated datasets of NOGD/NHIE (Non-Orthologous Gene Displacement/Non-Homologous Isofunctional Enzymes) and fold-switching proteins (FSPs), using Fisher’s exact test for statistical validation. Moonlighting proteins showed extraordinary enrichment for NOGD/NHIE (19.89% vs. 0.39% in non-moonlighting proteins; odds ratio = 63.1, p < 2.2 × 10−16) and strong enrichment for FSPs (6.99% vs. 0.26%; odds ratio = 28.7, p = 1.13 × 10−14), corresponding to ~51-fold and ~27-fold higher risks, respectively. These findings establish intrinsic structural plasticity—whether through evolutionary replacement (NOGD/NHIE) or conformational switching (FSP)—as a central mechanism enabling functional moonlighting in the human proteome. The results suggest that such plasticity facilitates functional innovation while preserving sequence integrity, and that both NOGD/NHIE and FSP features may serve as predictive signatures for identifying novel moonlighting proteins, particularly those with implications for disease mechanisms and therapeutic targeting. Full article
(This article belongs to the Special Issue Advances in Protein Structure-Function and Drug Discovery)
Show Figures

Figure 1

Back to TopTop